Literature DB >> 2113894

Assay of apolipoproteins A-1 and B by immunoturbidimetry: detection of individuals at risk for atherosclerotic artery disease.

D Sullivan1, F Kyne, S Maguire, D Sugrue, E Wright, L Garvey, D UaConaill.   

Abstract

Recent evidence has suggested that the levels of Apolipoprotein A-1 and B in plasma are better indicators of the risk of atherosclerotic artery disease than plasma lipids. This study describes the measurement of plasma Apolipoprotein A-1 and B by immunoturbidimetry in patients with atherosclerotic artery disease and in normal controls. Apoprotein B and the ratio of Apoprotein A-1/Apoprotein B were found to be the best discriminators between the two groups.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2113894     DOI： 10.1007/bf02946669

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  10 in total

Review 1.  Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias.

Authors:  P Alaupovic; W J McConathy; J Fesmire; M Tavella; J M Bard
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

Review 2.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Relationship of lipid disorders to coronary heart disease.

Authors:  C J Glueck
Journal:  Am J Med       Date:  1983-05-23       Impact factor: 4.965

5.  New assay of apolipoproteins A-I and B by rate nephelometry evaluated.

Authors:  J J Maciejko; S S Levinson; L Markyvech; M P Smith; R D Blevins
Journal:  Clin Chem       Date:  1987-11       Impact factor: 8.327

6.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

7.  An evaluation of the trends in analytical performance of international apolipoprotein A-1 and B assays.

Authors:  S J Smith; L O Henderson; G R Cooper; W H Hannon
Journal:  Clin Chem       Date:  1988-08       Impact factor: 8.327

8.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Authors:  A Sniderman; S Shapiro; D Marpole; B Skinner; B Teng; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

9.  Are apolipoproteins better discriminators than lipids for atherosclerosis?

Authors:  P Avogaro; G B Bon; G Cazzolato; G B Quinci
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

10.  International survey of apolipoproteins A1 and B measurements (1983-1984).

Authors:  G R Cooper; S J Smith; D A Wiebe; M Kuchmak; W H Hannon
Journal:  Clin Chem       Date:  1985-02       Impact factor: 8.327
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.